Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-18-049250)

Filing Details

Accession Number:: 0001104659-18-049250
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-08-02 17:51:52
Reporting Period:: 2018-07-31

Accepted Time:: 2018-08-02 17:51:52
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1641640	Nabriva Therapeutics Plc	NBRV	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1239650	D Daniel Burgess	1000 Continental Drive Suite 600 King Of Prussia PA 19406		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Acquisiton	2018-07-31	36,000	$2.75	36,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Ordinary Shares	Stock Option	Acquisiton	2018-08-01	15,000	$0.00	15,000	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
15,000		2028-08-01	No	4	A	Direct

Footnotes

The exercise price is $2.53 per share.
The option award was granted on August 1, 2018. The option award will vest in full on August 1, 2019.